AUTOIMMUNE CYTOPENIA
Clinical trials for AUTOIMMUNE CYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE CYTOPENIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE CYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody therapy targets hard-to-treat blood disorders
Disease control Recruiting nowThis study tests a new drug called CM336 for people with certain blood disorders (like low platelets or anemia) that have come back or not responded to other treatments. The drug works by helping the immune system stop attacking the body's own blood cells. About 158 adults will t…
Matched conditions: AUTOIMMUNE CYTOPENIA
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
500-Person study aims to crack the code of autoimmune diseases
Knowledge-focused Recruiting nowThis study is creating a new tool to help doctors diagnose and choose treatments for autoimmune diseases. Researchers will analyze blood samples from 500 children with autoimmune conditions and healthy children to find patterns in genes and other molecules. The goal is to make di…
Matched conditions: AUTOIMMUNE CYTOPENIA
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC